The UK Electrosurgery Market was valued at $215.9 Million in 2026 and projected to reach to $291.7 Million by 2031, representing a compound annual growth rate of 6.2%. The UK electrosurgery market is positioned for steady growth through 2031, with a CAGR of 6.2% reflecting increasing surgical volumes and technological advancement across the healthcare sector.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK electrosurgery market is valued at $215.9 million in 2026 and is projected to reach $291.7 million by 2031, demonstrating robust expansion driven by healthcare modernization and surgical innovation.
Both NHS trusts and private healthcare facilities across the UK are increasingly investing in advanced electrosurgical equipment, supported by government healthcare spending initiatives and private sector growth.
UK surgeons and hospitals are rapidly adopting minimally invasive techniques, driving demand for precision electrosurgical devices that reduce patient recovery times and improve surgical outcomes.
The UK's well-established healthcare infrastructure, regulatory framework, and high surgical procedure volumes create a favorable environment for electrosurgery technology adoption and market expansion.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | ORTHOPEDIC SURGERY (Surgery Type) |
| Forecast Period | 20262031 |
| Growth Rate | CAGR of 6.4% from 2026 to 2031 |
| Largest Segment | ELECTROSURGICAL INSTRUMENTS (Product) |
| Market Size Base Year (Billions) | ~USD 8.5 (2026) |
| Revenue Forecast (Billions) | ~USD 11.59 (2031) |
| Segments Covered | Product, Type, Surgery Type, End User |
4 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 122.3 | 130.2 | 137.4 | 144.4 | 151.1 | 157.4 | 163.5 | 169.3 | 4.3 |
| HOSPITALS & CLINICS | 254.2 | 273.6 | 291.8 | 309.9 | 328 | 345.4 | 362.7 | 379.6 | 5.4 |
| OTHERS | 24.6 | 25.8 | 26.8 | 27.7 | 28.6 | 29.4 | 30 | 30.6 | 2.7 |
| TOTAL | 401 | 429.6 | 456 | 482 | 507.7 | 532.2 | 556.3 | 579.6 | 4.9 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HENRY SCHEIN | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| HILL-ROM HOLDINGS, INC. | United States | Private Company | Patient Support Systems (beds, surfaces, mobility),Front Line Care (monitoring, diagnostics, respiratory),Surgical Solutions (tables, lights, pendants, positioning), |
| NIKKISO CO LTD | Japan | Public Company | Canned motor, reciprocating, and cryogenic submerged motor pumps and systems,Cryogenic heat transfer devices and process plants,Metering, mixing, and odorizing systems, |
| MEDTRONIC PLC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio, |
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal endoscopes and gastroenterology devices,Urology visualization and stone management,Respiratory and bronchoscopy systems, |
| CONMED CORPORATION | United States | Public Company | Orthopedic sports medicine & Hall power tools,General surgery, insufflation & smoke management,Endoscopic technologies (GI) and patient monitoring, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Interventional Cardiology & Structural Heart (incl. WATCHMAN FLX),Cardiac Rhythm Management & Remote Monitoring,MedSurg Endoscopy (GI, pancreaticobiliary, infection prevention), |
| SMITH+NEPHEW | United Kingdom | Public Company | Orthopaedics (Knee, Hip, Trauma & Extremities, Other Reconstruction),Sports Medicine & ENT,Advanced Wound Management Advanced Wound Care, |
| STRYKER CORPORATION | United States | Public Company | MedSurg and Neurotechnology,Orthopaedics Hips, Knees, Shoulders, Trauma and Extremities,Orthobiologics and Biosurgery, |
| THE COOPER COMPANIES, INC. | United States | Public Company | Sealing systems (dynamic, static, specialty, trims, Fortrex/FlexiCore/FlushSeal),Fuel and brake delivery systems,Fluid transfer and thermal management systems, |
| ZIMMER BIOMET | United States | Public Company | Knee reconstructive products,Hip reconstructive products,S.E.T. (sports medicine, biologics, foot & ankle, upper extremities, trauma, CMFT), |
| UTAH MEDICAL PRODUCTS, INC. | United States | Public Company | Obstetrics, neonatal, and NICU devices (fetal monitoring accessories, vacuum delivery, DISPOSA-HOOD, umbilical catheters, feeding and dialysis sets),Gynecology, womens health, and female sterilization (LETZ, Filshie Clip, electrosurgical tools, endometrial sampling, uterine manipulators),Pressure monitoring and BioPharm components (DELTRAN, BioPharm HP-PRT, molded parts, accessories), |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | United States | Public Company | Codman Specialty Surgical (neurosurgery and neurocritical care),Tissue Technologies skin and wound repair,Tissue Technologies nerve and tendon repair, |
Henry Schein is a publicly traded United States medical company founded in 1932 with 25,000 employees.
Hill-Rom Holdings, Inc. is a privately held United States medical company founded in 1915 with 10,000 employees.
Nikkiso Co Ltd is a publicly traded Japanese company founded in 1950 with 8,120 employees.
Medtronic PLC is a publicly traded medical technology company founded in 1949 with 95,000 employees and headquartered in Ireland.
Olympus Corporation is a publicly traded Japanese company founded in 1919 with 28,138 employees.
ConMed Corporation is a publicly traded United States medical device company founded in 1970 with 3,900 employees.
Boston Scientific Corporation is a publicly traded United States medical device company founded in 1979 with 59,000 employees.
Smith+Nephew is a publicly traded United Kingdom medical company founded in 1856 with 16,988 employees.
Stryker Corporation is a publicly traded United States medical technology company founded in 1941 with 56,000 employees.
The Cooper Companies, Inc. is a publicly traded United States medical company founded in 1960 with 18,000 employees.
Zimmer Biomet is a publicly traded United States medical device company founded in 1927 with 17,000 employees.
Utah Medical Products, Inc. is a publicly traded United States medical company founded in 1978 with 146 employees.
Integra LifeSciences Holdings Corporation is a publicly traded United States medical device company founded in 1989 with 4,427 employees.
The UK electrosurgery market is estimated at $215.9 million in 2026.
The UK electrosurgery market is forecast to reach $291.7 million by 2031.
The UK electrosurgery market is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2031.
Growth in the UK market is driven by aging demographics, rising chronic disease prevalence, adoption of minimally invasive techniques, and increased hospital capital investment in surgical technology.
The UK represents a significant European market with advanced healthcare infrastructure, strong regulatory standards, and high surgical procedure volumes that support steady market expansion.
The research study aimed to estimate the current market size of the electrosurgery market through several key activities. Comprehensive secondary research was conducted to gather information on the electrosurgery industry. The next step involved validating these findings, assumptions, and size estimates with industry experts across the value chain through primary research. To estimate the total market size, both top-down and bottom-up approaches were utilized. Following this, market segmentation and data triangulation procedures were employed to determine the sizes of different segments and subsegments within the electrosurgery market.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources, such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global electrosurgery market study. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts, such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the electrosurgery market. The primary demand-side sources include ambulatory surgical centers, hospitals, clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players and gather insights into key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:

Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. The tiers are as follows:
Tier 1 = > USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenue figures were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global electrosurgery market. All major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global electrosurgery market was split into various segments and sub-segments:
The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After determining the overall size of the global electrosurgery market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Electrosurgery is a surgical procedure that uses electric current to thermally destroy biological tissues through cutting, sealing, coagulation, or desiccation. Electrosurgery primarily requires generators, instruments, accessories, and smoke evacuation systems that operate on either traditional or advanced energy technologies.
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
COMPETITIVE LANDSCAPE ASSESSMENT
Full forecast, segment splits, and company analysis for all Electrosurgery Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report